AnalystsDaniel BusbyDaniel Busby's Stock Forecasts
AnalystsDaniel Busby
Analyst Ranking
Bottom 23%
#3808 out of 4929 analysts
Average Return
-8.58%
Win Rate
50%2 out of 4
Risk vs Reward
Poor
Good
Daniel Busby Analyst Color
Get additional color on Daniel Busby's coverage of popular stocks
Daniel Busby's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verrica Pharmaceuticals IncVRCA | 2 | Hold | $4.00 | N/A | Downgrades | 3 years ago |
Endo International PLCENDPQ | 1 | Hold | $5.00 | N/A | Maintains | 4 years ago |
Agile Therapeutics IncAGRX | 1 | Buy | $10,000.00 | N/A | Maintains | 4 years ago |
Pfizer IncPFE | 1 | Hold | $44.00 | N/A | Maintains | 4 years ago |
Mannkind CorpMNKD | 2 | Hold | $5.00 | N/A | Initiates Coverage On | 4 years ago |
Abbvie IncABBV | 1 | Buy | $135.00 | N/A | Reiterates | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.